Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital. Cunningham N, Shepherd S, Mohammed K, Lee KA, et al. Breast Cancer Res Treat 2022 Aug 17. pii: 10.1007/s10549-022-06703.

Read + Share

Amedeo Smart

Independent Medical Education

Cunningham N, Shepherd S, Mohammed K, Lee KA, et al. Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital. Breast Cancer Res Treat 2022 Aug 17. pii: 10.1007/s10549-022-06703.
PMID: 35976513